Skip to content
News & Events
in the news
David de Graaf now has his $28.5M launch round in place, building a coenzyme A platform in his latest startup
ENDPOINTS NEWS — Longtime biotech exec David de Graaf has the cash he needs to set up the preclinical foundation for his coenzyme A metabolism...